iSpecimen . vs Lexeo Therapeutics
iSpecimen . vs Lexeo Therapeutics, compared side by side on 22 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: iSpecimen . is on 46/100 and Lexeo Therapeutics on 61/100.
Where each one leads
iSpecimen .
Leads on none of the measures we hold for both companies.
Lexeo Therapeutics
- our overall score: 61/100 against 46/100
- headcount: 91 against 20
- funding raised: $495M against $1.0M
- LinkedIn following: 16,654 against 2,812
At a glance
| Measure | iSpecimen . | Lexeo Therapeutics |
|---|---|---|
| What it is | Global marketplace connecting researchers with human biospecimens for life science research. | Clinical-stage genetic medicine company developing AAV-mediated treatments for cardiovascular and Alzheimer's diseases. |
| Category | Biotech, HealthTech, Genomics, Clinical Trials | Biotech, MedTech, HealthTech, Genomics |
| Sells toBusiness model | B2B | B2B |
| Offering | Marketplace | Platform |
| Founded | 2007 | 2020 |
| Headquarters | Plainsboro, United States | New York City, United States |
| Status | Active | Active |
Size, funding and growth
| Measure | iSpecimen . | Lexeo Therapeutics |
|---|---|---|
| Employees | 20 | 91 |
| Total funding | $1.0M | $495M |
| Latest round | Seed | Public Offering |
| LinkedIn followers | 2,812 | 16,654 |
StartupHub scores
Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.
| Measure | iSpecimen . | Lexeo Therapeutics |
|---|---|---|
| StartupHub scoreOur 0-100 rating | 46/100 | 61/100 |
| Traction | 43/100 | 60/100 |
| Team | Not published | 70/100 |
| Community | 8/100 | 8/100 |
| Search visibility | 34/100 | 28/100 |
| Quality | 58/100 | 68/100 |
| Agent readinessHow well an AI agent can read and act on the site | D (42/100) | D (40/100) |
| Domain ratingLink authority, 0-100 | 39/100 | 41/100 |
Technology
Detected on each public site, so it reflects the marketing stack as well as the product.
| Measure | iSpecimen . | Lexeo Therapeutics |
|---|---|---|
| Hosting | Not detected | Self Managed |
| CDN | Cloudflare | Not detected |
| CMS | WordPress | WordPress |
| Frameworks | Jquery, Bootstrap | Jquery |
| Analytics | Google Tag Manager | Google Tag Manager |
| Open source | Yes | No |
iSpecimen . vs Lexeo Therapeutics: common questions
Which is better, iSpecimen . or Lexeo Therapeutics?
On our 0-100 score Lexeo Therapeutics rates higher (61/100 against 46/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 22 data points above: read the rows that match what you are buying for.
How do iSpecimen . and Lexeo Therapeutics compare on the numbers?
Lexeo Therapeutics leads on our overall score (61/100 against 46/100), headcount (91 against 20), funding raised ($495M against $1.0M), LinkedIn following (16,654 against 2,812).
Read the full iSpecimen . review and pricing or the Lexeo Therapeutics review and pricing. You can also browse other iSpecimen . alternatives we track.